Picture of Celemics logo

331920 Celemics Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Celemics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2,256-4,713-5,238-4,797-3,876
Depreciation
Amortisation
Non-Cash Items-3,465-376-52.7-677-1,948
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-362-1891,255431434
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-5,367-4,553-3,201-4,150-4,534
Capital Expenditures-138-422-574-551-219
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,449-21,3222,0131,4455,494
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2,311-21,7441,4398945,275
Financing Cash Flow Items40.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2,18128,053-109-476-407
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8731,745-1,869-3,726333